Clinical Trial: Safety and Efficacy of the Therapy With BREINMAX® for the Treatment of Patients With Asthenia After COVID-19
Study Status: Completed
Recruit Status: Completed
Condition:
Asthenia
COVID-19
Study Type: Interventional
Official Title: Prospective Multicentre Comparative Randomized Double Blind Placebo Controlled Study of Safety and Efficacy of the Therapy With BREINMAX® for the Treatment of Patients With Asthenia After Having the N
Brief Summary:
This is prospective multicentre comparative randomized double blind placebo controlled study conducted in 6 medical facilities.The objective of the study is to assess the safety and efficacy of the sequential therapy with BREINMAX®, solution for intravenous infusion and intramuscular injection, and BREINMAX®, capsules for the treatment of patients with asthenia after having the novel coronavirus infection (COVID-19)
Read more